Prostate News Archive
04-Jun-2007
Prostate Cancer: How Docs Influence Patient Choices (Newsweek)
A new study finds that men with early prostate cancer are strongly influenced by the type of specialists they consult. Deciding on a treatment. Findings Of Immunotherapy Vaccine In Prostate Cancer Patients Shown (Science Daily)
Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, but who have not yet developed metastatic disease was presented by researchers. The study showed that sipuleucel-T did not significantly delay the ... Treatment For Early Prostate Cancer Associated With Type Of Specialist Seen (Science Daily)
A new study analyzing men with localized prostate cancer shows that the specialty of the physician they see can influence the type of therapy they ultimately receive. The study found that patients aged 65 to 69 years old who consult a urologist are more likely to undergo surgery to remove the prostate, while those who consult a radiation oncologist and a urologist, regardless of age, usually ... Treatment for early prostate cancer associated with type of specialist seen (EurekAlert!)
Chicago, June 3, 2007 -- A new study analyzing men with localized prostate cancer shows that the specialty of the physician they see can influence the type of therapy they ultimately receive.
Back to Prostate News Archive
